microdosing glp 1 alzheimer's GLP-1R agonists protect against disease by rewiring energy regulation Microdosing GLP-1s: Safety, Dosage, Side

Do we add GLP1's for all with personal or family history of substance abuse and/or obesity, metabolic syndrome and/or T2DM

As NAD+ levels decline with age, obesity, and metabolic disease, sirtuin function diminishes, contributing to insulin resistance, mitochondrial dysfunction, and fat accumulation

That is an important distinction to understand before starting

JPEN J Parenter Enteral Nutr

Moreover, CICR requires continual activation of VDCCs by Ca 2+ within intracellular microdomains, but not by robust Ca 2+ influx from extracellular spaces [8,15,17,24]

In humans, various isoforms of ADA have been identified that differ in molecular weight, kinetic properties and tissue distribution